Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks Real-World dupixent use for EoE

NCT ID NCT06693531

Knowledge-focused Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times

Summary

This study watches how people with eosinophilic esophagitis (EoE) use the medicine Dupixent in everyday care. Researchers will collect information from about 350 patients to learn more about the disease and how treatment affects symptoms and quality of life. No new treatments are tested; the goal is to gather knowledge to help future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

368 people

The number who actually took part.

Started

Nov 2024

Expected to finish

May 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The target population comprises of patients (≥1 years old) who are initiating treatment with DUPIXENT® for EoE according to the United States Prescribing Information (USPI)

Ages

1 year and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: 1. Initiating treatment with DUPIXENT® for EoE according to the USPI 2. Participants aged ≥12 years and caregivers or legal guardians of participants aged \<12 years must be able to understand and complete registry-related questionnaires Key Exclusion Criteria: 1. Patients who have a contraindication to DUPIXENT® according to the USPI 2. Treatment with DUPIXENT® within the 6 months prior to the screening assessment 3. Participation in an ongoing interventional study on or within 6 months of the baseline assessment. Once enrolled in registry, participation is allowed in other ongoing studies (at the discretion of the registry investigator) NOTE: Other protocol defined inclusion/exclusion criteria apply

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eosinophilic esophagitis (EOE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

eosinophilic esophagitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eosinophilic esophagitis (EOE)

Contacts and locations

Locations

  • Allergy & Asthma Specialists, P.S.C.

    Owensboro, Kentucky, 42301, United States

  • Allergy Partners of N.J., P.C.

    Ocean City, New Jersey, 07712, United States

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611, United States

  • Arizona Digestive Health/GI Alliance

    Sun City, Arizona, 85351, United States

  • Arkansas Childrens Hospital

    Little Rock, Arkansas, 72202, United States

  • Atrium Health / Wake Forest University School of Medicine

    Winston-Salem, North Carolina, 27157, United States

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Boston Childrens Hospital

    Boston, Massachusetts, 02115, United States

  • Boston Specialists, Chinatown Office

    Boston, Massachusetts, 02111, United States

  • Brooke Army Medical Center

    Fort Sam Houston, Texas, 78234, United States

  • Childrens Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Comprehensive Gastrointestinal Health, LLC

    Libertyville, Illinois, 60048, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • Emory Healthcare, Emory Clinic

    Atlanta, Georgia, 30322, United States

  • Endeavor Health, Skokie Campus

    Skokie, Illinois, 60077, United States

  • GI Alliance

    Southlake, Texas, 76092, United States

  • GI Associates and Endoscopy Center

    Flowood, Mississippi, 39232, United States

  • GI Care for Kids LLC

    Atlanta, Georgia, 30342, United States

  • Gastroenterology Group of Rochester LLP

    Rochester, New York, 14618, United States

  • Gastroenterology of Greater Orlando

    Orange City, Florida, 32763, United States

  • Great Lakes Gastroenterology Research, LLC

    Mentor, Ohio, 44060, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • Kansas City VA Medical Center

    Kansas City, Missouri, 64128, United States

  • Kansas Gastroenterology LLC

    Wichita, Kansas, 67226, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Northwestern University, Feinberg School of Medicine

    Chicago, Illinois, 60611, United States

  • Orlando Health

    Orlando, Florida, 32806, United States

  • Palmetto Gastroenterology Clinical Research

    Summerville, South Carolina, 29486, United States

  • Phoenix Childrens Hospital

    Phoenix, Arizona, 85016, United States

  • Rocky Mountain Gastroenterology

    Littleton, Colorado, 80120, United States

  • Scripps Clinic

    La Jolla, California, 92037, United States

  • Seattle Children's Home Health Company

    Seattle, Washington, 98105, United States

  • Stanford University

    Palo Alto, California, 94304, United States

  • Steven And Alexandra Cohen Children's Medical Center Of New York

    Lake Success, New York, 11042, United States

  • Susquehanna Research Group

    Camp Hill, Pennsylvania, 17011, United States

  • Tanner Clinic

    Layton, Utah, 84041, United States

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • UConn Health - The Carole and Ray Neag Comprehensive Cancer Center

    Farmington, Connecticut, 06030, United States

  • University of California Los Angeles (UCLA)

    Los Angeles, California, 90024, United States

  • University of California San Francisco (UCSF)

    San Francisco, California, 94115, United States

  • University of California, San Francisco

    Oakland, California, 94609, United States

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Southern California Keck School of Medicine

    Los Angeles, California, 90033, United States

  • University of Virginia

    Charlottesville, Virginia, 22908, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

  • Washington Gastroenterology, GIA

    Tacoma, Washington, 98405, United States

  • Washington University in Saint Louis

    St Louis, Missouri, 63110, United States

  • Weil Cornell Medicine NYP

    New York, New York, 10021, United States

  • Yale School of Medicine

    New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.